Dr. David Lee Dai Wee is a distinguished Clinical Oncologist renowned for his expertise in early-phase clinical trials, thoracic oncology, and head and neck oncology. He is the first Malaysian to receive the IASLC Academy Award (2024) and has also been honored with the ASCO International Development and Education Award (2024). With a commitment to advancing cancer care, he has contributed to over 40 early-phase clinical trials and actively participates in ASCO committees. Dr. Lee champions a collaborative, multidisciplinary approach to personalized treatment plans, integrating the latest oncological advancements.